Manufacturers Life Insurance Company, The Forma Therapeutics Holdings, Inc. Transaction History

Manufacturers Life Insurance Company, The

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Aug 11, 2023	SELL	$7.12 - $20.24 $4,870 - $13,844	-684 Reduced 4.25%	15,404 $307,000
Q3 2022 Nov 03, 2022	SELL	$7.12 - $20.24 $4,870 - $13,844	-684 Reduced 4.25%	15,404 $307,000
Q2 2022 Aug 11, 2023	BUY	$5.1 - $10.0 $1,249 - $2,450	245 Added 1.55%	16,088 $110,000
Q2 2022 Aug 15, 2022	BUY	$5.1 - $10.0 $1,249 - $2,450	245 Added 1.55%	16,088 $111,000
Q1 2022 Aug 11, 2023	BUY	$8.34 - $14.69 $132,130 - $232,733	15,843 New	15,843 $147,000
Q1 2022 May 20, 2022	SELL	$8.34 - $14.69 $27,246 - $47,992	-3,267 Reduced 17.1%	15,843 $147,000
Q4 2021 Feb 16, 2022	BUY	$13.6 - $24.89 $14,456 - $26,458	1,063 Added 5.89%	19,110 $272,000
Q3 2021 Nov 12, 2021	SELL	$21.22 - $25.7 $424 - $514	-20 Reduced 0.11%	18,047 $419,000
Q2 2021 Aug 12, 2021	BUY	$22.86 - $30.95 $31,432 - $42,556	1,375 Added 8.24%	18,067 $450,000
Q1 2021 May 03, 2021	BUY	$24.58 - $42.82 $163,088 - $284,110	6,635 Added 65.97%	16,692 $468,000
Q4 2020 Feb 12, 2021	BUY	$34.9 - $51.08 $49,627 - $72,635	1,422 Added 16.47%	10,057 $351,000
Q3 2020 Nov 09, 2020	BUY	$32.95 - $50.25 $284,523 - $433,908	8,635 New	8,635 $430,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.